J. Fessel

发表

Quality of Life and Disability in Patients with Treatment-Failure Gout

H. Schumacher, L. Frank, P. Gorevic, 2009, The Journal of Rheumatology.

Abnormal oligodendrocyte function in schizophrenia explains the long latent interval in some patients

J. Fessel, 2022, Translational Psychiatry.

There are many potential medical therapies for atraumatic osteonecrosis.

J. Fessel, 2013, Rheumatology.

Metabolic effects of a growth hormone-releasing factor in patients with HIV.

D. Potvin, S. Grinspoon, D. Kotler, 2007, The New England journal of medicine.

Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing

J. Fessel, 2021, Alzheimer's & dementia.

Smoking and cryptococcosis in AIDS patients

G. Friedman, L. Hurley, N. Udaltsova, 2006, Mycoses.

Prevention of Alzheimer's dementia may be within reach

J. Fessel, 2022, Clinical and Translational Discovery.

A randomized, double-blind trial comparing azithromycin and clarithromycin in the treatment of disseminated Mycobacterium avium infection in patients with human immunodeficiency virus.

P. Cahn, R. Benner, C. Hicks, 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Quantitation Of Human Cytomegalovirus DNA From Peripheral Blood Cells Of Human Immunodeficiency Virus-Infected Patients Could Predict Cytomegalovirus Retinitis

T. Merigan, D. Zipeto, L. Rasmussen, 1995 .

Incidence of pancreatitis in HIV-infected patients: comment on findings in EuroSIDA cohort.

L. Hurley, J. Fessel, 2008, AIDS.

Phase 3 Study of Ibalizumab for Multidrug‐Resistant HIV‐1

Gary Richmond, S. Weinheimer, Princy Kumar, 2018, The New England journal of medicine.

If ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease, then increasing TGFBR2 might be therapeutic

J. Fessel, 2020, Alzheimer's & dementia.

The paradox of opposite directions of gene expressions in MCI and AD suggests possible therapy to prevent progression of MCI to AD

J. Fessel, 2020, Alzheimer's & dementia.

Formulating treatment of major psychiatric disorders: algorithm targets the dominantly affected brain cell-types

J. Fessel, 2023, Discover Mental Health.

Amyloid is essential but insufficient for Alzheimer causation: addition of subcellular cofactors is required for dementia

J. Fessel, 2018, International journal of geriatric psychiatry.

Quantitation of human cytomegalovirus DNA from peripheral blood cells of human immunodeficiency virus-infected patients could predict cytomegalovirus retinitis.

T. Merigan, D. Zipeto, L. Rasmussen, 1995, The Journal of infectious diseases.

Fluoxetine plus lithium for treatment of mental health impairment in Long Covid

J. Fessel, 2022, Discover Mental Health.

Cure of Alzheimer’s Dementia Requires Addressing All of the Affected Brain Cell Types

J. Fessel, 2023, Journal of clinical medicine.

Supplementary Pharmacotherapy for the Behavioral Abnormalities Caused by Stressors in Humans, Focused on Post-Traumatic Stress Disorder (PTSD)

J. Fessel, 2023, Journal of clinical medicine.

Does use of potent antiretroviral therapy differ by health care setting?

S. Follansbee, L. Hurley, J. Fessel, 1999, JAMA.

The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia

J. Fessel, 2020, Alzheimer's & dementia.

Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence

J. Fessel, 2021, Alzheimer's & dementia.

Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs

J. Fessel, 2019, Alzheimer's & dementia.

A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons

J. Fessel, 2021, Alzheimer's & dementia.

Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease

J. Fessel, 2020, Alzheimer's & dementia.

Evidence for genetic regulation of susceptibility to toxoplasmic encephalitis in AIDS patients.

J. Montoya, A. Zolopa, M. Schrappe, 1996, The Journal of infectious diseases.

Prevalence of Drug-Resistant Minority Variants in Untreated HIV-1–Infected Individuals With and Those Without Transmitted Drug Resistance Detected by Sanger Sequencing

J. Fessel, 2017 .

Ineffective levels of transforming growth factors and their receptor account for old age being a risk factor for Alzheimer's disease

J. Fessel, 2019, Alzheimer's & dementia.

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation

D. Potvin, S. Grinspoon, D. Kotler, 2008, AIDS.

Alzheimer's disease combination treatment.

J. Fessel, 2017, Neurobiology of Aging.

Cure of Alzheimer’s Dementia in Many Patients by Using Intranasal Insulin to Augment an Inadequate Counter-Reaction, Edaravone to Scavenge ROS, and 1 or 2 Other Drugs to Address Affected Brain Cells

J. Fessel, 2023, Journal of clinical medicine.

Analysis of Why Alzheimer’s Dementia Never Spontaneously Reverses, Suggests the Basis for Curative Treatment

J. Fessel, 2023, Journal of clinical medicine.

Data-adaptive Selection Of The Adjustment Set In Variable Importance Estimation

Mark J. van der Laan, Oliver Bembom, Robert W. Shafer, 2008 .

Reversing Alzheimer's disease dementia with clemastine, fingolimod, or rolipram, plus anti‐amyloid therapy

J. Fessel, 2022, Alzheimer's & dementia.

Personalized, Precision Medicine to Cure Alzheimer’s Dementia: Approach #1

J. Fessel, 2024, International journal of molecular sciences.

The several ways to authentically cure Alzheimer’s dementia

J. Fessel, 2023, Ageing Research Reviews.

Formulating Treatment to Cure Alzheimer’s Dementia: Approach #2

J. Fessel, 2024, International journal of molecular sciences.

Special Issue “Pathophysiology and Treatment of Alzheimer’s Disease”

J. Fessel, 2024, International journal of molecular sciences.

All GLP-1 Agonists Should, Theoretically, Cure Alzheimer’s Dementia but Dulaglutide Might Be More Effective Than the Others

J. Fessel, 2024, Journal of clinical medicine.